1. Academic Validation
  2. Benzoyl 2-methyl indoles as selective PPARgamma modulators

Benzoyl 2-methyl indoles as selective PPARgamma modulators

  • Bioorg Med Chem Lett. 2005 Jan 17;15(2):357-62. doi: 10.1016/j.bmcl.2004.10.068.
John J Acton 3rd 1 Regina M Black A Brian Jones David E Moller Lawrence Colwell Thomas W Doebber Karen L Macnaul Joel Berger Harold B Wood
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. john_acton@merck.com
Abstract

Routine screening for human PPAR ligands yielded compounds 1 and 2, both of which were sub-micromolar hPPARgamma agonists. Synthetic modifications of these leads led to a series of potent substituted 3-benzyl-2-methyl indoles, a subset of which were noted to be selective PPARgamma modulators (SPPARgammaMs). SPPARgammaM 24 displayed robust anti-diabetic activity with an improved therapeutic window in comparison to a PPARgamma full agonist in a rodent efficacy model.

Figures